期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 54, 期 3, 页码 1338-1342出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01197-09
关键词
-
资金
- TaiGen Biotechnology Co., Taipei, Taiwan
- National Health Research Institutes, Zhunan, Taiwan [96 A1-CLPP01-014]
The in vitro antibacterial activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, against 770 clinical isolates were investigated. Nemonoxacin (tested as its malate salt, TG-875649) showed better in vitro activity than ciprofloxacin and levofloxacin against different species of staphylococci, streptococci, and enterococci, Neisseria gonorrhoeae, and Haemophilus influenzae. The in vitro activity of TG-875649 was also comparable to or better than that of moxifloxacin against these pathogens, which included ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus and levofloxacin-resistant Streptococcus pneumoniae.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据